carlisle medical
Refill Requests shipment tracking contact carlisle medical
knowledge center
generic drug updates
07/25/2017
Launch of Generic Relpax
The generic equivalent of Relpax (Eletriptan) has just been released, following FDA approval. Relpax is FDA-approved for the acute treatment of migraine with or without an aura in adults. Eletriptan will be available in 20 and 40mg strengths. ... Full Story
05/31/2017
Launch of Generic Strattera
The generic equivalent of Strattera (Atomoxetine) has just been released, following FDA approval. Strattera is FDA-approved to treat ADHD (Attention deficit hyperactivity disorder). Strattera is available in several strengths, (10, 18, 25, 40, 60,... Full Story
05/31/2017
Launch of Generic Butrans
The FDA has recently approved the generic equivalent of Butrans (Buprenorphine) transdermal patches. Butrans is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which... Full Story
04/27/2017
Launch of Generic Vytorin
The generic equivalent of Vytorin (ezetimibe/simvastatin) has just been released, following FDA approval. Vytorin is indicated for the treatment of primary hyperlipidemia and homozygous familial hypercholesterolemia. Vytorin is a combination drug... Full Story
03/01/2017
Launch of Generic Pristiq
The generic equivalent of Pristiq (Desvenlafaxine) has just been released, following FDA approval. Pristiq is used to treat major depressive disorder. All generic drugs approved by the FDA have the same quality, strength, purity and stability as... Full Story
01/06/2017
Generic Oxycontin ER -- Temporarily Unavailable in Certain Strengths
The generic version of Oxycontin ER (oxycodone extended-release) is currently not available in the 10mg and 20mg strengths. According to the manufacturer, Teva Pharmaceuticals, these strengths are currently unavailable and a time frame to resume... Full Story
12/27/2016
Launch of Generic EpiPen
The generic equivalent of EpiPen (epinephrine) is now available from Mylan. The EpiPen is used to treat severe/life-threatening allergic reactions to insect stings/bites, foods, drugs and other allergens. Mylan is also the manufacturer of the brand... Full Story
12/12/2016
Launch of Generic Zetia
The FDA has recently approved the generic equivalent of Zetia (ezetimibe). Zetia is used to treat high cholesterol by reducing the amount of cholesterol absorbed by the body. Zetia is manufactured in the 10mg strength and the generic ezetimibe is... Full Story
11/02/2016
Launch of Generic Seroquel XR
The FDA has recently approved the generic equivalent of Seroquel XR (quetiapine fumarate extended-release tablets). Seroquel XR is used to treat psychiatric conditions (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression... Full Story
10/28/2016
EpiPen Alternative Is Available
A generic equivalent of Adrenaclick (epinephrine auto-injector) is available from Impax Laboratories. The epinephrine auto-injector is an emergency injection of epinephrine. It is used to treat severe allergic reactions to insect stings/bites,... Full Story
10/27/2016
Launch of Generic Benicar and Benicar HCTZ
The FDA has recently approved the generic equivalent of Benicar and Benicar HCTZ (olmesartan medoxomil and olmesartan medoxomil hydrochlorothiazide). Benicar is used to treat high blood pressure by keeping the blood vessels from narrowing and... Full Story
06/01/2016
Launch of Generic Nuvigil
The generic equivalent of Nuvigil (armodafinil) has just been released, following FDA approval. Nuvigil is used to treat excessive sleepiness caused by sleep apnea, narcolepsy or shift work sleep disorder. Generic prescription drugs approved by... Full Story
05/03/2016
Launch of Generic Equivalent: Crestor (Rosuvastatin)
The generic equivalent of Crestor (rosuvastatin) has just been released, following FDA approval. Crestor is used to lower cholesterol and to slow down plaque buildup in arteries. All generic drugs approved by the FDA have the same quality,... Full Story
04/28/2016
Brand-name Vivlodex™ and Generic MOBIC
Vivlodex™ is a low-dose nonsteroidal anti-inflammatory drug (NSAID) new option for people suffering from the degenerative joint condition, osteoarthritis (OA). Recently approved by the US Food and Drug Administration (FDA), this pain treatment... Full Story
03/28/2016
Launch of Generic Voltaren 1% Gel
The generic equivalent of Voltaren 1% topical gel (diclofenac sodium) has just been released, following FDA approval. Voltaren 1% topical gel is used to treat joint pain by reducing hormones in the body that cause inflammation and pain. Like the... Full Story
03/23/2016
Launch of Generic Frova
The generic equivalent of Frova (frovatriptan succinate) has just been released, following FDA approval. Frova is used to treat acute migraine headaches with or without auras. All generic drugs approved by the FDA have the same quality,... Full Story
03/23/2016
Launch of Generic Nasonex
The generic equivalent of Nasonex (mometasone) has just been released, following FDA approval. Nasonex is used to treat the nasal symptoms of allergies. This includes congestion, sneezing and a runny nose. Generic prescription drugs approved by... Full Story
03/15/2016
Launch of Generic Enablex
The generic equivalent of Enablex (darifenacin) has just been released, following FDA approval. Enablex is used to reduce muscle spasms of the bladder and urinary tract. It is often prescribed to treat the symptoms of an overactive bladder and... Full Story
02/02/2016
Launch of Generic Glumetza
The generic equivalent of Glumetza (Metformin HCI ER) has just been released. Glumetza is an oral diabetes medicine prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. This medication is... Full Story
12/09/2015
Launch of Generic Patanol
The generic equivalent of Patanol (olopatadine) has just been launched. Patanol is an antihistamine that reduces the natural chemical histamine in the body. It is used to treat itching, burning, redness, watering and other eye symptoms caused by... Full Story
10/12/2015
Launch of Generic Avodart
The generic equivalent of Avodart 0.5mg (dutasteride) is now available. Avodart is a prescription medication prescribed to treat an enlarged prostate and works by blocking the conversion of testosterone into DHT (dihydrotestosterone), thereby... Full Story
09/04/2015
Launch of Generic ConZip
The generic equivalent of ConZip (tramadol hydrochloride extended-release) capsules is now available in 100, 200 and 300mg strengths. Tramadol is used for the management of moderate to moderately severe chronic pain. The extended-release capsules... Full Story
07/13/2015
Launch of Generic Namenda Tablets
The generic equivalent of Namenda (memantine hydrochloride) has just been launched in the 5mg and 10mg strengths. Namenda reduces the actions of chemicals in the brain that may contribute to the symptoms of Alzheimer's disease. Namenda (memantine... Full Story
07/08/2015
Launch of Generic Axert Tablets
The generic equivalent of Axert (almotriptan) has just been launched in the 6.25mg and 12.5mg strengths. Axert is used to treat migraine headaches. It helps to reduce pain and other symptoms of migraine headaches, including sensitivity to light and... Full Story
07/01/2015
Launch of Generic Aggrenox
The generic equivalent of Aggrenox (aspirin/extended release dipyridamole) capsules has just been announced by Teva Pharmaceutical Industries Ltd. in the United States. Aspirin and extended release dipyridamole capsules are used to lower the risk of... Full Story
06/23/2015
Launch of Generic Zyvox
The generic equivalent of Zyvox (Linezolid) has just been released, following approval from the U.S. Food and Drug Administration (FDA). Zyvox is an antibiotic used to treat bacterial infections such as pneumonia and certain types of skin... Full Story
04/28/2015
Launch of Generic Abilify
The generic equivalent of Abilify (Aripiprazole) has just been released in multiple strengths, following FDA approval. Abilify is an antipsychotic medication. It is used to treat schizophrenia and bipolar disorder. Abilify can also be prescribed in... Full Story
03/11/2015
Launch of Generic Naprelan CR Tablets
The generic equivalent of Naprelan CR tablets (naproxen sodium controlled release) has just been launched, following approval by the FDA (Food and Drug Administration.) Naprelan is a member of the nonsteroidal anti-inflammatory drugs (NSAIDs) group.... Full Story
02/17/2015
Launch of Generic Nexium
The generic equivalent of Nexium (esomeprazole) has been released, following FDA approval. Nexium treats gastroesophageal reflux disease (GERD) by reducing the amount of acid produced in the stomach. At the time of this announcement, one... Full Story
02/04/2015
Over the Counter Flonase – Now Available
Over the counter (OTC) Flonase is now available in 60 and 120-spray sizes. Flonase (Fluticosone Propionate nasal spray) is used for symptoms of upper respiratory allergies and is formulated to provide 24-hour non-drowsy allergy relief. With this... Full Story
01/26/2015
Generic Nexium Approved by FDA
The FDA has recently approved the generic equivalent of Nexium (esomeprazole). Nexium treats gastroesophageal reflux (GERD) by reducing the amount of acid produced in the stomach. An official launch date has yet to be announced by the... Full Story
01/12/2015
Launch of Generic Colcrys 0.6mg
The generic equivalent of Colcrys 0.6mg (colchicine 0.6mg) has just been released, following FDA approval. Colcrys 0.6mg reduces the pain of gout flares and helps prevent future flairs. Generic prescription drugs approved by the FDA have the... Full Story
12/03/2014
Anticipated Launch of Generic Celebrex
It is anticipated the generic launch of Celebrex (celecoxib) is imminent, following approval by the U.S. Food and Drug Administration (FDA) earlier this year. Initially, the generic celecoxib will have 180-day marketing exclusivity by a limited... Full Story
10/27/2014
Launch of Generic Patanase®
The generic equivalent of Patanase® (olopatadine) has just been launched, following FDA approval. Patanase® is an antihistamine which reduces sneezing, itching, watery eyes and runny nose. Generic prescription drugs approved by the FDA have the... Full Story
10/01/2014
Carlisle Pharmacy News -- Launch of Generic Oxycontin CR
The generic equivalent of Oxycontin CR (Oxycodone HCl ER) has just been released, following FDA approval. Oxycontin CR is a Schedule II narcotic and is used to treat moderate to severe pain. Generic prescription drugs approved by the FDA have the... Full Story
09/30/2014
Launch of Generic Exforge®
The generic equivalent of Exforge® (amlodipine besylate, valsartan) has just been released, following FDA approval. Exforge® is an angiotensin that relaxes the muscles in your heart for improved blood flow. Generic prescription drugs approved by... Full Story
09/17/2014
Launch of Generic Fortesta Gel Pump
The generic equivalent of Fortesta Gel Pump (testosterone gel) has just been released, following FDA approval. Fortesta Gel Pump is used by adult men to treat the symptoms of low testosterone levels or no testosterone levels. Generic... Full Story
08/25/2014
Carlisle Medical Pharmacy News -- Upcoming First Time Generic Releases
It is anticipated the following Brand medications will have a generic drug launched the third and fourth quarter of 2014. As new generics are launched, Carlisle Medical contacts prescribing physicians to make them aware. If you have any... Full Story
08/06/2014
OTC Flonase Expected to Be Available in Early 2015
The FDA has recently approved Flonase Allergy Relief to be an OTC treatment for temporary relief of symptoms for upper respiratory allergies. Flonase is the first, and only, OTC nasal spray indicated for relief of all allergy symptoms. OTC Flonase... Full Story
07/07/2014
Re-Launch of Generic Astepro
The generic equivalent of Astepro (azelastine) has just been re-launched, following FDA approval. Astepro is used to prevent sneezing, runny nose and other symptoms of nasal allegries. Generic prescription drugs approved by the FDA have the same... Full Story
07/07/2014
Launch of Generic Diovan
The generic equivalent of Diovan (valsartan) has just been released, following FDA approval. Diovan is used to treat high blood pressure (HBP). Generic prescription drugs approved by the FDA have the same high quality and strength as brand name... Full Story
06/11/2014
Launch of Generic Actonel 150mg
The generic equivalent of Actonel 150mg (risendronate sodium tablets) has just been released, following FDA approval. Actonel 150mg is used to treat or prevent osteoporosis in men and women. It is also used to treat Paget's disease of bone. It works... Full Story
06/11/2014
Launch of Generic Testim® 1% gel
The generic equivalent of Testim® 1% gel (testosterone gel) has just been released, following FDA approval. Testim® 1% gel is used by adult men to treat the symptoms of low testosterone levels or no testosterone levels. Generic prescription... Full Story
05/29/2014
Launch of Generic Pennsaid 1.5%
The generic equivalent of Pennsaid 1.5% (diclofenac sodium topical solution) has just been released, following FDA approval. Pennsaid is a non-steroidal anti-inflammatory drug (NSAID). It works by reducing hormones that cause inflammation and pain... Full Story
05/27/2014
New Medication Update: Nexium® 24HR
Pfizer, Inc. has announced the introduction in the U.S. of over-the-counter (OTC) Nexium® 24HR. The active ingredient in Nexium® 24HR is esomeprazole 20mg, which is a part of a group of medications called proton pump inhibitors or PPIs. Nexium® 24HR... Full Story
05/19/2014
Launch of Generic Exalgo® Extended Release Tablets
The generic equivalent of Exalgo® extended release tablets (hydromorphone hydrochloride) has just been released, following FDA approval. Exalgo® is prescribed to treat moderate to severe pain. Generic prescription drugs approved by the FDA have... Full Story
04/18/2014
Launch of Generic Lovaza® Capsules
The generic equivalent of Lovaza® capsules (omega-3-acid ethyl esters) has just been released, following FDA approval. Lovaza® is prescribed to treat high cholesterol. Generic prescription drugs approved by the FDA have the same high quality and... Full Story
04/15/2014
Lunesta Generic Release
The generic equivalent of Lunesta tablets (eszopiclone) has been released, following FDA approval. Lunesta is a widely prescribed sedative used to treat insomnia. During the 180-day exclusivity period, multiple companies have received FDA approval... Full Story
03/01/2014
New Medication - Zohydro
Zohydro, a new opioid narcotic painkiller, has recently been released in the 10mg, 15mg, and 20mg strengths. Higher strengths have not yet been released. Zohydro has a CII classification and may have serious side effects, if not used properly.... Full Story
02/04/2014
Generic Avinza Capsules
The generic equivalent of Avinza capsules (Morphine Sulphate capsules, extended release) has just been released, following FDA approval. The extended form of this medicine is used for round-the-clock treatment of pain. This form of morphine is not... Full Story
01/13/2014
Micardis Generic Release
The generic equivalent of Micardis tablets (telmisartan) has just been released, following FDA approval. Micardis is prescribed to treat high blood pressure. During the 180-day exclusivity period, multiple companies have received FDA approval to... Full Story
01/02/2014
Generic Detrol LA Capsules®
On Thursday, January 2, Teva Pharmaceuticals launched the generic equivalent of Detrol LA® extended-release capsules (tolterodine tartrate) following FDA approval. Detrol® LA (tolterodine ER) is a long-acting drug used to treat overactive... Full Story
12/11/2013
Cymbalta® Delayed-Release Capsule Launch
Effective December 11, 2013, the generic equivalent of Cymbalta® delayed-release capsules (duloxetine HCI) was released, following FDA approval. Cymbalta® is one of the most widely prescribed treatments for depression, anxiety and other disorders.... Full Story
11/11/2013
Launch of Generic Aciphex® 20mg Tablets
On Friday, November 8, Lupin Pharmaceuticals, Inc., launched the generic equivalent of Aciphex® delayed-release tablets 20mg (rabeprazole sodium) following the expiration of pediatric exclusivity. Rabeprazole sodium is used for the short-term... Full Story
09/24/2013
Launch of Generic Niaspan® Extended-Release Tablets
Teva Pharmaceuticals has launched generic Niaspan® Extended-Release Tablets, which received FDA Approval in April 2005 and can now be released based on a settlement with the brand manufacturer. Niacin therapy is indicated as an adjunct to diet... Full Story
09/24/2013
Launch of Generic Nitrolingual® Pump Spray
On September 20, 2013, Perrigo received final FDA approval and launched the generic equivalent of Arbor’s brand product Nitrolingual® Pump Spray. Perrigo is exclusive in the market, with 180 day exclusivity on this product. Estimated U.S. annual... Full Story
09/17/2013
Generic Lidoderm 5% Patch Launches
Actavis Pharma, Inc. has launched generic Lidoderm® (lidocaine patch 5%), which received FDA approval on August 23, 2012. Inventory will begin arriving in distribution centers on Monday, September 16. Lidoderm (lidocaine patch 5%) is used to... Full Story
08/01/2013
Generic Trilipix Capsules Launch
On July 15, 2013, Global Pharmaceuticals received final FDA approval and commenced shipping for generic Trilipix capsules (fenofibric acid). Abbott's branded product Trilipix capsules had annual U.S. brand sales of approximately $554M for the 12... Full Story
05/20/2013
Generic Zomig launches
On May 14, 2013, Global Pharmaceuticals launched the Authorized Generic (AG) for Zomig and Zomig-ZMT (zolmitriptan and zolmitriptan ODT), Impax Pharma’s branded product. Annual U.S. brand sales for both products combined is $200M. Zomig and... Full Story
04/03/2013
Generic Zovirax® Launches
On Wednesday, April 3, generic Zovirax® ointment launched. Annual US brand sales of the 30gm tubes of brand Zovirax (acyclovir) were approximately $230M. Acyclovir is indicated in the management of initial genital herpes and in limited... Full Story
03/19/2013
Generic Luvox® CR Launches
On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of Jazz Pharma’s Luvox® CR (fluvoxamine extended release) capsules. Luvox® CR is indicated for the treatment of obsessive compulsive disorder (OCD),... Full Story
03/11/2013
Generic Suboxone® Launches
On March 5, 2013, Amneal Pharmaceuticals LLC announced that its generic equivalent of Suboxone®, Buprenorphine HCl and Naloxone HCl Dihydrate Tablets, 2mg/0.5mg and 8mg/2mg, may be shipped to pharmacies for dispensing and sale to the... Full Story
03/11/2013
Generic Zometa® Launches
Generic Zometa® Launches - On March 5, 2013, Sagent Pharmaceuticals received final FDA approval and launched the generic equivalent of Zometa® (zoledronic acid). Novartis' branded product had annual U.S. sales of approximately $1.2B. Zometa® is... Full Story
03/04/2013
Generic Antara® Launches
On Friday, February 22, Mylan received final FDA approval and launched the generic equivalent of Lupin's Antara® (micronized fenofibrate). Annual U.S. brand sales of this product were $53 million. Antara® is indicated as adjunctive therapy to... Full Story
02/18/2013
Generic Sulfamylon® Launches
On February 2, 2013, Par Pharmaceutical received final FDA approval for and commenced shipping the generic equivalent for Mylan’s branded product, Sulfamylon® (mafenide acetate) topical solution. Sulfamylon® had estimated total U.S. annual sales of... Full Story
02/04/2013
Generic Olux E Foam® Launches
On February 1, 2013, Perrigo received final FDA approval for and commenced shipping the generic equivalent for Stiefel Laboratories’ branded product, Olux E Foam® (clobetasol propionate). Olux E Foam® had estimated total U.S. annual sales of... Full Story
01/28/2013
Generic Clarinex Reditabs® Launch
On January 23, 2013, Dr. Reddy’s Laboratories commenced shipping the generic equivalent for Merck’s branded product, Clarinex Reditabs® (desloratadine ODT) tablets. Clarinex Reditabs® had estimated total U.S. annual sales of approximately $7... Full Story
01/28/2013
Generic Bactroban® Launches
On January 25, 2013, Glenmark received final FDA approval for and commenced shipping the generic equivalent for GlaxoSmithKline’s branded product, Bactroban® (mupirocin) cream. Bactroban® had estimated total U.S. annual sales of approximately $70... Full Story
01/21/2013
Generic Lamictal XR® Launches
On January 18, 2013, Par Pharmaceuticals received final FDA approval and commenced shipping the AB-rated generic equivalent for GlaxoSmithKline’s branded product, Lamictal XR® (lamotrigine) tablets. Lamictal XR® had estimated total U.S. annual sales... Full Story
01/21/2013
Generic Luxiq® Launches
On January 15, 2013, Perrigo received final FDA approval for and commenced shipping the generic equivalent for GlaxoSmithKlines’s branded product, Luxiq® (betamethasone valerate) foam. Luxiq® had estimated total U.S. annual sales of approximately... Full Story
01/15/2013
Generic Opana ER® Launches
On January 7, 2013, Global Pharmaceutical received final FDA approval for and commenced shipping the generic equivalent for Endo’s branded product, Opana ER® (oxymorphone HCL) tablets. Opana ER® had estimated total U.S. annual sales of approximately... Full Story
01/15/2013
Generic Duetact® Launches
On January 8, 2013, Sandoz received final FDA approval for and commenced shipping the generic equivalent for Takeda’s branded product, Duetact® (pioglitazone HCL) tablets. Duetact® had estimated total U.S. annual sales of approximately $30... Full Story
01/07/2013
Generic of Dilantin® Chewable Tablets Launches
On December 27, 2012, Mylan received final FDA approval for the generic equivalent of Pfizer’s Dilantin® Chewable Tablets. Dilantin Infatabs® had estimated total U.S. annual sales of approximately $16.5 million for the twelve months ending September... Full Story
01/07/2013
Generic of Maxalt® Launches
On December 31, 2012, Apotex received final FDA approval for and commenced shipping the generic equivalent for Merck’s branded product, Maxalt® (rizatriptan benzoate) tablets. Maxalt® had estimated total U.S. annual sales of approximately $336... Full Story
01/07/2013
Generic of Maxalt-MLT® Launches
On December 31, 2012, Mylan received final FDA approval for and commenced shipping the generic equivalent for Merck’s branded product, Maxalt-MLT® (rizatriptan benzoate) orally disintegrating tablets. Maxalt-MLT® had estimated total U.S. annual... Full Story
01/07/2013
Generic of Propecia® Launches
On January 2, 2013, Dr. Reddy’s commenced shipping the generic equivalent for Merck’s branded product, Propecia® (finasteride) tablets. Propecia® had estimated total U.S. annual sales of approximately $150 million. Propecia is indicated for the... Full Story
11/21/2012
Generic Gabitril® Launches
On October 18, Caraco received final FDA approval and launched the generic equivalent of Teva Pharmaceutical’s branded product Gabitril®. Gabitril® is indicated as adjunctive therapy in adults and children 12 years or older in the treatment of... Full Story
11/19/2012
Update on Generic Vicodin®
By January 1, 2014, FDA is limiting the amount of acetaminophen to 325mg per pill or 15ml dose. Any products with more than 325mg acetaminophen will no longer be available on the market after this date. Abbott Laboratories recently announced the... Full Story
11/19/2012
Generic Arthrotec®
On November 1, 2012, Greenstone commenced shipping the Authorized Generic (AG) for Pfizer’s branded product Arthrotec® (diclofenac sodium, misoprostol). For the twelve months ending May 31, 2012, Arthrotec® had total U.S. sales of approximately $130... Full Story
03/08/2012
March Generic Drug Releases
Generic Equivalent of Geodon® Launches Dr. Reddy's Laboratories received final FDA approval and launched their AB-rated generic of Pfizer's Geodon® (ziprasidone hydrochloride capsules). Geodon (ziprasidone) is indicated for the treatment of... Full Story
02/29/2012
February Generic Drug Releases
LAUNCH OF GENERIC LEXAPRO® As of February 29, an authorized generic for escitalopram oxalate has become available. This product is the generic version of Forest Laboratories’ branded product, Lexapro®. Lexapro (escitalopram) is indicated for the... Full Story
01/09/2012
January Generic Drug Releases
Generic Ritalin LA® Capsules Launched Actavis Group commenced shipping their AB rated generic equivalent of Novartis' Ritalin LA® Capsules in the 20, 30, and 40mg strengths (100-count bottle). Ritalin LA® (methylphenidate hydrochloride)... Full Story
12/28/2011
December Generic Drug Releases
Generic — Lipitor® On November 30th, Watson launched the authorized generic version of Lipitor® (atorvastatin calcium) tablets. Watson has received all FDA approvals. Lipitor® is a prescription medicine that is used along with a low-fat diet.... Full Story
11/21/2011
November Generic Drug Release
Authorized Generic of Kadian® Capsules Launches On November 10th, Watson received final FDA approval and launched their generic version of Kadian® capsules. -MORPHINE SU ER CAP 20, 30, 50, 60, 80,100MG Morphine is used to relieve moderate... Full Story
11/18/2011
October Generic Drug Release
Teva announced on October 24th that they received final FDA approval to market, distribute, and sell the blockbuster generic equivalent of Zyprexa® (olanzapine) tablets 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg. Olanzapine is used to treat the... Full Story
07/21/2011
July 2011 Generics
The following workers compensation related generics are now available to the market: Oxymorphone Hydrochloride Extended-Release 7.5mg & 15mg Tablet (generic for Opana ER) Alfuzosin HCL 10mg Tablet (generic for... Full Story
07/20/2011
June 2011 Generics
The following workers compensation related generics are now available to the market: Triamcinolone Acetonide 55 mcg Spray (generic for Nasacort AQ) Levofloxacin 250mg, 500mg and 750mg Tablet (generic for... Full Story
07/19/2011
May 2011 Generics
The following workers compensation related generics are now available to the market: Methylphenidate HCL 18mg, 27mg, 36mg, & 54mg Extended-Release 24 tablet (generic for Concerta) Cyclobenzaprine HCL 15mg & 30 mg Extended-Release 24 Capsule... Full Story
05/31/2011
April 2011 Generics
The following workers compensation related generics are now available to the market: Paroxetine HCL Extended-Release Tablets, 37.5mg - Mylan Pharmaceuticals, Inc. (generic for Paxil CR Tablets) Cyclobenzaprine Hydrochloride Extended-Release... Full Story
05/31/2011
March 2011 Generics
The following workers compensation related generics are now available to the market: Epinastine Hydrochloride Ophthalmic Solution, 0.05% - Cypress Pharmaceutical, Inc. (generic for Elestat Ophthalmic... Full Story
05/31/2011
February 2011 Generics
The following workers compensation related generics are now available to the market: Gabapentin Oral Solution, 250mg/5ml - Hi-Tech Pharmacal Co., Inc. (generic for Neurontin Oral Solution) ... Full Story
05/30/2011
January 2011 Generics
The following workers compensation related generics are now available to the market: Amlodipine Besylate/Benazepril Oral Capsule 10mg-40 & 5mg-40m (generic for... Full Story
03/21/2011
December 2010 Generics
The following workers compensation related generics are now available to the market: Zolpidem Tartrate extended-release tablets, 12.5mg - ANCHEN PHARMACEUTICALS, INC. (generic for Ambien CR tablets, 12.5mg) Levofloxacin Ophthalmic Solution,... Full Story
12/29/2010
July 2010 Generic Drugs
Doxycycline delayed-released capsules, 40 mg (30 mg immediate release and 10 mg delayed-released) – MYLAN PHARMACEUTICALS, INC. – Oracea Capsules – 07/01/10 Clindamycin Palmitate Hydrochloride for oral solution USP, 75 mg (BASE)/5ML – PADDOCK... Full Story
12/29/2010
August 2010 Generic Drugs
Venlafaxine Hydrochloride Extended-Release tablets, 37.5 mg (BASE), 75 mg (BASE) and 150 mg (BASE) – SUN PHARMA GLOBAL, INC. – Venlafaxine HCL Extended-Release Tablets – 08/18/10 Atomoxetine Hydrochloride Capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60... Full Story
08/03/2010
June 2010 Releases
Chlorzoxazone Tablets USP, 375 mg and 750 mg – MIKART, INC. – Brand Name: PARAFON FORTE DSC CAPLETS – approval date 6/1/2010 (Muscle... Full Story
08/03/2010
June 2010 Releases
Oxymorphone Hydrochloride Extended-Release Tablets, 5 mg, 10 mg, 20 mg and 40 mg – IMPAX LABORATORIES, INC. – Brand Name: OPANA ER TABLETS – approval date 6/14/2010 (Pain... Full Story
03/18/2010
February 2010 – Generic Drug Updates
DESLORATADINE TABLETS, 5 mg, Orchid Healthcare, Clarinex tablets... Full Story
02/17/2010
November 2009 Generic Drug Releases
Ketorolac Tromethamine Ophthalmic solution, .4%. by APOTEX, INC. Brand Name: ACULAR LS Ophthalmic solution Ketorolac Tromethamine Ophthalmic solution, .5% by ALCON, INC. Brand Name: ACULAR Ophthalmic solution Ketorolac Tromethamine... Full Story
10/31/2009
October 2009 - Generic Drug Updates
Polyethylene Glycol 3350 powder for solution, (OTC), 17 grams/scoopful by Kremers Urban Development Company for Miralax for oral solution (constipation) Buprenorphine Hydrochloride Sublingual tablets, 2 MG (BASE) and 8 MG (BASE), by Roxane... Full Story
09/30/2009
September Generic Releases
Temazepam Capsules USP,7.5 MG by Mutual Pharmaceutical Company, Inc. for Restoril Capsules... Full Story
08/31/2009
August Generic Releases
Clonidine Transdermal System, USP0.1 MG/Day, 0.2 MG/Day and 0.3 MG/Day by Aveva Drug Delivery Systems, for Catapres-TTS (blood... Full Story
07/31/2009
July Generic Release Date
Triamcinolone Acetonide Nasal Spray, 0.055 MG/Spray by Barr Laboratories, Inc., for Nasacort AQ Nasal Spray 0.055 MG/Spray... Full Story
06/30/2009
June Generic Releases
Omeprazole Magnesium delayed release capsules, (OTC) 20 MG (base) for Prilosec OTC delayed release capsules (heartburn). Oxcarbazepine oral suspension, 200 MG/5ML for Trileptal oral suspension... Full Story
04/30/2009
April Generic Releases
Topiramate Capsules (Sprinkle), 15 MG and 25 MG by Barr Laboratories, Inc., for Topamax Sprinkle Capsules (nerve pain/anti-convulsant) Topiramate Capsules (Sprinkle), 15 MG and 25 MG by Cobalt Laboratories, Inc., for Topamax Sprinkle Capsules... Full Story
03/31/2009
March Generic Releases
Levalbuterol Inhalation Solution USP, 0.25% for Xopenex Inhalation Solution (lung conditions). Ibuprofen Capsules, 200 MG for Advil Liquid Gels Capsules (liquid filled capsule). Topiramate Tablets, 25 MG, 50 MG, 100 MG and 200 MG for Topamax... Full Story
01/31/2009
January Generic Releases
The following workers compensation related generics are now available to the market: Alprazolam orally disintegrating tablets, o.25 mg, 0.5 mg, 1 mg, and 2 mg for Nirvam orally disintegrating tablets... Full Story
11/30/2008
November Generic Releases
The following workers compensation related generics are now available to the market: Levetiracetam Tablets, 250 MG, 500 MG, and 750 MG for Keppra Tablets (epilepsy) Budesonide Inhalation Suspension for Pulmicort Respules Inhalation Suspension... Full Story
10/31/2008
October Generic Releases
The following workers compensation related generics are now available to the market: Dorzolamide HCL & Timolol Maleate Ophthalmic Solution for Cospot Ophthalmic Solution... Full Story
09/30/2008
September Generic Releases
The following workers compensation related generic releases are now available to the market: Galantamine Hydrobromide Extended Release Capsules 8 MG, 16 MG, and 24 MG for Razadyne ER... Full Story
08/31/2008
August Generic Releases
The following workers compensation related generics are now available: Galantamine Tablets, 4 MG, 8 MG, and 12 MG for Razadyne Tablets... Full Story
07/31/2008
July Generic Releases
The following workers compensation related generics are now available to the market: Divalproex Sodium Delayed-Release Tablets, 125 MG, 250 MG, and 500 MG for Depakote Delayed Release Tablets (depression and... Full Story
06/30/2008
June Generic Releases
The following workers compensation generics are now available to the market: Zalepon Capsules, 5 MG and 10 MG for Sonata Capsules (sedative) Risperidone Tablets USP, 0.25 MG, 0.5 MG, 1 MG, 2 MG, 3 MG and 4 MG for Risperdal Tablets (bipolar... Full Story
05/31/2008
May Generic Releases
The following workers compensation related generics are now available to the market: Ropinirole Hydrochloride Tablets .25 MG, .5 MG, 1 MG, 2 MG, 3 MG, and 4 MG for Requip (Parkinsons Disease and Restless Leg... Full Story
04/30/2008
April Generic Releases
The following workers compensation related generics are now available to the market: Lithium Carbonate Capsules USP, 600 MG for Lithium Carbonate Capsules USP (depression) Donepezil Hydrochloride Tablets 5 MG and 10 MG for Aricept Tablets... Full Story
02/28/2008
February Generic Releases
The following workers compensation related generics are now available to the market: Alendrontate Sodium Tablets for Fosamax Tablets (osteoporosis) Pramipexole Dihydrochloride Tablets for Mirapex Tablets (Restless Leg Syndrome and Parkinson... Full Story
12/31/2007
December Generic Releases
The following workers compensation related generics are now available to the market: Extended Phenytoin Sodium Capsules, USP 30 MG for Dilantin (antiepileptic... Full Story
10/31/2007
October Generic Releases
The following workers compensation related generics are now available to the market: Albuterol Sulfate for Accundeb Inhalation Solution (Asthma) Nifedipine Extended Release Tablets USP, 90 MG for Procardia XL Tablets (Heart Disease) Hydrocodone... Full Story
09/12/2007
September Generic Releases
The following workers compensation related generics are now available to the market: Albuterol/Ipratropium for Duoneb (Inhaler) Metoprolol ER for Toprol XL (Hypertension) Carvedilol Tabs for Coreg... Full Story
05/25/2007
May Generic Releases
The following workers compensation related generics are now available to the market: Amlodipine Besylate for Norvasc (hypertension) Zolpidem Tartrate for Ambien (insomnia) Amlodipine Benazepril for Lotrel (hypertension)... Full Story
04/02/2007
New Generics
The following workers compensation related generics are now available to the market: Propranolol/Hydrochloride for Inderol (hypertension) Trandolapril for Tarka (hypertension) Moexipril/Hydrochlorothiazide for Univasc (hypertension)... Full Story
12/31/2006
Workers Compensation Generic Drugs Released in 12/06
The following workers compensation related generics are now available to the market: Metoprolol ER for Toprol-XL (hypertension) Amoxicillin for Amoxil (antibiotic) Lisin+HCTZ for Prinizine (hypertension) Penicil-VK for V-Cillin... Full Story
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2017 Carlisle & Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer